Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q3 EPS Loss of $0.10
Go back to Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q3 EPS Loss of $0.10| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 26.59 +0.20 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.39 | 52 Week High | $42.49 | |||
| Open | $26.65 | 52 Week Low | $16.64 | |||
| Day High | $26.72 | P/E | N/A | |||
| Day Low | $26.40 | EPS | $-0.42 | |||
| Volume | 74,810 | |||||
